Endpoints News
1,267 FOLLOWERS
Endpoints News is an independent news organization, reports and analyzes the top global biotech and pharmaceutical R&D news of the day. We produce original editorials daily on business deals, buyouts, and corporate reorganizations to FDA actions and the latest clinical data on some of the world's most closely watched drugs.
Endpoints News
2d ago
Welcome back to Endpoints Weekly. Our reporters tracked a flurry of deals and data readouts this week, plus updates on the Trump administration’s health agency picks. Let’s dive in. The Trump administration pulled its nomination ..read more
Endpoints News
2d ago
Mehmet Oz has committed to defending Medicare drug price negotiations in court if he is confirmed to lead CMS. The nominee sailed through a roughly three-hour confirmation hearing on Friday, despite being pressed by members ..read more
Endpoints News
2d ago
The US Court of Appeals for the Federal Circuit on Friday ruled against Regeneron in a closely-watched patent infringement case involving the New York biotech's blockbuster eye drug Eylea and Amgen's competing biosimilar Pavblu, which ..read more
Endpoints News
2d ago
The once-fledgling field of MASH drug developers is now one of the few areas of consistency in the biotech industry. And another late-stage startup is gaining traction. Boston Pharmaceuticals, advancing a once-monthly liver disease drug ..read more
Endpoints News
2d ago
The UK government is planning to double the proportion of money drugmakers have to pay back on medicine sales to the National Health Service in a move that’s drawn backlash from industry. In the UK ..read more
Endpoints News
2d ago
Greg Behar’s shakeup of Recipharm is paying off in his first year as CEO. The CDMO reported record-high revenues on Friday, and the company expects it will be able to tap into the booming GLP ..read more
Endpoints News
2d ago
HHS Secretary Robert F. Kennedy Jr. and his staff last Wednesday hosted a regenerative medicine roundtable primarily to discuss how to lower regulatory barriers for stem cell treatments, three people familiar with the meeting confirmed ..read more
Endpoints News
2d ago
Plus, news about Heidelberg, Accropeutics, Allarity Therapeutics, Cadrenal and Inovio: Altimmune to test its incretin in addiction: Following the path set by Novo Nordisk last week, Altimmune said Thursday at its R ..read more
Endpoints News
3d ago
Sutro Biopharma is reducing its headcount by 50%, appointing a new CEO, shutting down its only factory, and shifting away from its lead candidate. The major reshuffle is intended to save cash, which the company ..read more
Endpoints News
3d ago
→ Celeste Warren said in a LinkedIn post that she is retiring from Merck on July 7. Warren joined Merck in 1997 and has been VP of the company’s Global Diversity ..read more